<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK385627" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK385627/" /><meta name="ncbi_pagename" content="GRIN2A-Related Speech Disorders and Epilepsy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>GRIN2A-Related Speech Disorders and Epilepsy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="GRIN2A-Related Speech Disorders and Epilepsy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/09/29" /><meta name="citation_author" content="Kenneth A Myers" /><meta name="citation_author" content="Ingrid E Scheffer" /><meta name="citation_pmid" content="27683935" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK385627/" /><meta name="citation_keywords" content="Glutamate receptor ionotropic, NMDA 2A" /><meta name="citation_keywords" content="GRIN2A" /><meta name="citation_keywords" content="GRIN2A-Related Speech Disorders and Epilepsy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="GRIN2A-Related Speech Disorders and Epilepsy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Kenneth A Myers" /><meta name="DC.Contributor" content="Ingrid E Scheffer" /><meta name="DC.Date" content="2016/09/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK385627/" /><meta name="description" content="GRIN2A-related speech disorders and epilepsy are characterized by speech disorders in all affected individuals and a range of epilepsy syndromes present in about 90%. Severe speech disorders observed can include dysarthria and speech dyspraxia, and both receptive and expressive language delay/regression; more mildly affected individuals may display subtly impaired intelligibility of conversational speech. Epilepsy features include seizure onset usually between ages three and six years, focal epilepsy with language and/or global developmental regression, and electroencephalogram (EEG) showing continuous spike-and-wave discharges in sleep or very active centrotemporal discharges. Seizure types include seizures associated with aura of perioral paresthesia, focal or focal motor seizures (often evolving to generalized tonic-clonic), and atypical absence seizures. Epilepsy syndromes can include: Landau-Kleffner syndrome (LKS), epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS), childhood epilepsy with centrotemporal spikes (CECTS), atypical childhood epilepsy with centrotemporal spikes (ACECTS), autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD), and infantile-onset epileptic encephalopathy." /><meta name="og:title" content="GRIN2A-Related Speech Disorders and Epilepsy" /><meta name="og:type" content="book" /><meta name="og:description" content="GRIN2A-related speech disorders and epilepsy are characterized by speech disorders in all affected individuals and a range of epilepsy syndromes present in about 90%. Severe speech disorders observed can include dysarthria and speech dyspraxia, and both receptive and expressive language delay/regression; more mildly affected individuals may display subtly impaired intelligibility of conversational speech. Epilepsy features include seizure onset usually between ages three and six years, focal epilepsy with language and/or global developmental regression, and electroencephalogram (EEG) showing continuous spike-and-wave discharges in sleep or very active centrotemporal discharges. Seizure types include seizures associated with aura of perioral paresthesia, focal or focal motor seizures (often evolving to generalized tonic-clonic), and atypical absence seizures. Epilepsy syndromes can include: Landau-Kleffner syndrome (LKS), epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS), childhood epilepsy with centrotemporal spikes (CECTS), atypical childhood epilepsy with centrotemporal spikes (ACECTS), autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD), and infantile-onset epileptic encephalopathy." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK385627/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/grin2a-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK385627/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AC4D3DFC869A1000000000709038E.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK385627_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK385627_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/grin1-ndd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/grin2b/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK385627_"><span class="title" itemprop="name"><i>GRIN2A</i>-Related Speech Disorders and Epilepsy</span></h1><p class="contrib-group"><span itemprop="author">Kenneth A Myers</span>, MD, PhD, FRCPC and <span itemprop="author">Ingrid E Scheffer</span>, FAA, FAHMS, FRACP, MBBS, PhD.</p><a data-jig="ncbitoggler" href="#__NBK385627_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK385627_ai__"><div class="contrib half_rhythm"><span itemprop="author">Kenneth A Myers</span>, MD, PhD, FRCPC<div class="affiliation small">University of Melbourne<br />Melbourne, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@1nek.ufs" class="oemail">moc.liamg@1nek.ufs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ingrid E Scheffer</span>, FAA, FAHMS, FRACP, MBBS, PhD<div class="affiliation small">University of Melbourne<br />Melbourne, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.ude.bleminu@reffehcs.i" class="oemail">ua.ude.bleminu@reffehcs.i</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 29, 2016</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="grin2a-dis.Summary" itemprop="description"><h2 id="_grin2a-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>GRIN2A</i>-related speech disorders and epilepsy are characterized by speech disorders in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and a range of epilepsy syndromes present in about 90%. Severe speech disorders observed can include dysarthria and speech dyspraxia, and both receptive and expressive language delay/regression; more mildly affected individuals may display subtly impaired intelligibility of conversational speech. Epilepsy features include seizure onset usually between ages three and six years, focal epilepsy with language and/or global developmental regression, and electroencephalogram (EEG) showing continuous spike-and-wave discharges in sleep or very active centrotemporal discharges. Seizure types include seizures associated with aura of perioral paresthesia, focal or focal motor seizures (often evolving to generalized tonic-clonic), and atypical absence seizures. Epilepsy syndromes can include: Landau-Kleffner syndrome (LKS), epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS), childhood epilepsy with centrotemporal spikes (CECTS), atypical childhood epilepsy with centrotemporal spikes (ACECTS), <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> rolandic epilepsy with speech dyspraxia (ADRESD), and infantile-onset epileptic encephalopathy.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a <i>GRIN2A</i>-related speech disorder and epilepsy is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of a <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Significant speech/language deficits require therapy from a speech pathologist. Seizures should be treated with antiepileptic drugs (AEDs). Many different AEDs may be effective, and no one medication has been demonstrated to be effective specifically for these disorders.</p><p><i>Prevention of secondary complications:</i> Monitoring for possible adverse effects of AEDs.</p><p><i>Surveillance:</i> Developmental surveillance in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children; routine monitoring of speech and language by a speech pathologist should be considered for all children, particularly those diagnosed before reaching school age.</p><p><i>Agents/circumstances to avoid:</i> In individuals with ECSWS, phenytoin, barbiturates and carbamazepine should be avoided as they are rarely effective, may worsen the EEG, and have negative effects on neuropsychological outcomes.</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to clarify the genetic status of apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from prompt evaluation for speech disorders and/or seizures and institution of treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>GRIN2A</i>-related speech disorders and epilepsy are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The proportion of <i>GRIN2A</i>-related speech disorders and epilepsy caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown. Each child of an individual with a <i>GRIN2A</i>-related speech disorder and epilepsy has a 50% chance of inheriting the <i>GRIN2A</i> pathogenic variant. Once the <i>GRIN2A</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible options.</p></div></div><div id="grin2a-dis.Diagnosis"><h2 id="_grin2a-dis_Diagnosis_">Diagnosis</h2><div id="grin2a-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>In general, a <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <b>should be considered</b> in an individual presenting with an otherwise unexplained combination of the following speech disorders and/or epilepsy features, seizure types, epilepsy syndromes [<a class="bk_pop" href="#grin2a-dis.REF.tsai.2013.280">Tsai et al 2013</a>].</p><p><b>Speech disorders</b></p><ul><li class="half_rhythm"><div>Acquired aphasia</div></li><li class="half_rhythm"><div>Auditory agnosia (impaired recognition of sounds)</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Speech dyspraxia</div></li></ul><p><b>Epilepsy features</b></p><ul><li class="half_rhythm"><div>Onset in early childhood (usually age 3-6 years)</div></li><li class="half_rhythm"><div>Focal epilepsy with language and/or global developmental regression</div></li><li class="half_rhythm"><div>Electroencephalogram (EEG) showing continuous spike-and-wave discharges in sleep or very active centrotemporal discharges</div></li></ul><p><b>Seizure types</b></p><ul><li class="half_rhythm"><div>Most commonly, focal seizures</div></li><li class="half_rhythm"><div>Sometimes occurring with an aura of perioral paresthesia, and often evolving to generalized tonic-clonic seizures</div></li></ul><p><b>Epilepsy syndromes</b></p><ul><li class="half_rhythm"><div>Landau-Kleffner syndrome (LKS)</div></li><li class="half_rhythm"><div>Epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS)</div></li><li class="half_rhythm"><div>Childhood epilepsy with centrotemporal spikes (CECTS)</div></li><li class="half_rhythm"><div>Atypical childhood epilepsy with centrotemporal spikes (ACECTS)</div></li><li class="half_rhythm"><div>Autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD)</div></li><li class="half_rhythm"><div>Infantile-onset epileptic encephalopathy</div></li></ul><p>Note: Detailed descriptions of each epilepsy syndrome can be found in <a href="#grin2a-dis.Clinical_Description">Clinical Description</a>.</p></div><div id="grin2a-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>GRIN2A</i>-related speech disorder and epilepsy <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of either a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GRIN2A</i> or a heterozygous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving <i>GRIN2A</i> using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK385627/table/grin2a-dis.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figgrin2adisTmoleculargenetictestingu" rid-ob="figobgrin2adisTmoleculargenetictestingu">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or single-gene testing) or <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis or comprehensive genomic sequencing).</p><p>Gene-targeted testing requires that the clinician develop a hypothesis about which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may not. The phenotypes of many genetic epileptic encephalopathies overlap; thus, most children with a <i>GRIN2A</i>-related speech disorder and epilepsy are diagnosed by CMA or <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> (see <a href="#grin2a-dis.Recommended_Testing">Recommended Testing</a>) or by comprehensive genomic sequencing (see <a href="#grin2a-dis.Testing_to_Consider">Testing to Consider</a>).</p><div id="grin2a-dis.Recommended_Testing"><h4>Recommended Testing</h4><p><b>Chromosomal microarray analysis (CMA</b>) using oligonucleotide or SNP arrays is recommended first when developmental impairment/intellectual disability and/or <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features are present. The ability to determine the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> depends on the type of microarray used and the density of probes in the 16p13.2 region.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that incorporates both <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> and includes <i>GRIN2A</i> and other genes of interest (see <a href="#grin2a-dis.Differential_Diagnosis">Differential Diagnosis</a>) is recommended when epilepsy associated with speech dyspraxia and dysarthria are the primary findings (see <a class="figpopup" href="/books/NBK385627/table/grin2a-dis.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figgrin2adisTmoleculargenetictestingu" rid-ob="figobgrin2adisTmoleculargenetictestingu">Table 1</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likley to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="grin2a-dis.Testing_to_Consider"><h4>Testing to Consider</h4><p><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> alone is insufficient to support <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>GRIN2A,</i> followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found may be considered first in individuals with features that are highly suggestive of <i>GRIN2A</i>-related speech disorder and epilepsy. However, because many of these features overlap with those of other genetic epileptic encephalopathies, multigene panels or comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing are often performed in lieu of single-gene testing.</p><div id="grin2a-dis.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>GRIN2A</i>-Related Speech Disorders and Epilepsy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK385627/table/grin2a-dis.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__grin2a-dis.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GRIN2A</i></td><td headers="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">58/71</td></tr><tr><td headers="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13/71&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CMA</td><td headers="hd_h_grin2a-dis.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 7</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="grin2a-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK385627/#grin2a-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="grin2a-dis.TF.1.2"><p class="no_margin">See <a href="#grin2a-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="grin2a-dis.TF.1.3"><p class="no_margin">Based on the combined results of published reports of <i>GRIN2A</i>-related disorders [<a class="bk_pop" href="#grin2a-dis.REF.endele.2010.1021">Endele et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.reutlinger.2010.1870">Reutlinger et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.lesca.2012.1526">Lesca et al 2012</a>, <a class="bk_pop" href="#grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.devries.2013.482">DeVries &#x00026; Patel 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.conroy.2014.858">Conroy et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.dimassi.2014.370">Dimassi et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.yuan.2014.3251">Yuan et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.allen.2016.e12">Allen et al 2016</a>, <a class="bk_pop" href="#grin2a-dis.REF.fainberg.2016.97">Fainberg et al 2016</a>]. In one <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, <i>GRIN2A</i> was disrupted by an inherited <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> detectable by <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> [<a class="bk_pop" href="#grin2a-dis.REF.endele.2010.1021">Endele et al 2010</a>]; this was categorized as "detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>."</p></div></dd><dt>4. </dt><dd><div id="grin2a-dis.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="grin2a-dis.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications. These methods will detect from single-exon to whole-gene deletions; however, breakpoints of large deletions and/or deletion of adjacent genes may not be detected by these methods.</p></div></dd><dt>6. </dt><dd><div id="grin2a-dis.TF.1.6"><p class="no_margin">Of these 13 probands: 9 had small losses of genetic material (&#x0003c;292 kb), resulting in partial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GRIN2A</i>; 3 had large deletions (&#x0003e;0.9 Mb) affecting multiple genes (in 2 of the 3 <i>GRIN2A</i> was entirely deleted); and 1 had a small intragenic <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a>.</p></div></dd><dt>7. </dt><dd><div id="grin2a-dis.TF.1.7"><p class="no_margin">CMA is appropriate to define breakpoints of large deletions.</p></div></dd></dl></div></div></div></div></div></div><div id="grin2a-dis.Clinical_Characteristics"><h2 id="_grin2a-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="grin2a-dis.Clinical_Description"><h3>Clinical Description</h3><p>The clinical spectrum of <i>GRIN2A</i>-related speech disorders and epilepsy is broad and may vary within a family (e.g., from mild <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> speech impairment to rolandic epilepsy with speech dyspraxia) [<a class="bk_pop" href="#grin2a-dis.REF.turner.2015b.35">Turner et al 2015b</a>].</p><p>Disease progression is variable: some individuals have normal development and spontaneous remission of seizures, while others develop medically refractory epilepsy and severe developmental impairment. Language and/or global developmental regression often occurs in those with the more severe epilepsy-aphasia disorders.</p><p><b>Speech and language</b> were impaired in 100% of individuals in a study of the speech manifestations of <i>GRIN2A-</i>related disorders [<a class="bk_pop" href="#grin2a-dis.REF.turner.2015a.586">Turner et al 2015a</a>]. Abnormalities included dysarthria and speech dyspraxia, and both receptive and expressive language delay/regression.</p><p>Mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may display subtly impaired intelligibility of conversational speech, most commonly characterized by hypernasality, imprecise consonant production, and impaired pitch and prosody [<a class="bk_pop" href="#grin2a-dis.REF.turner.2015a.586">Turner et al 2015a</a>].</p><p><b>Intellectual disability,</b> observed in 38%-67% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, ranges from mild to severe [<a class="bk_pop" href="#grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</a>].</p><p><b>Epilepsy</b> occurs in approximately 90% of individuals [<a class="bk_pop" href="#grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</a>].</p><p>Seizure onset is typically between ages three and six years (mean 4.6 years), although individuals may present from infancy to adolescence [<a class="bk_pop" href="#grin2a-dis.REF.endele.2010.1021">Endele et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.lesca.2012.1526">Lesca et al 2012</a>, <a class="bk_pop" href="#grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</a>].</p><p>The most common seizure type overall is focal seizures. These are often associated with an aura of perioral paresthesia, and frequently evolve to generalized tonic-clonic convulsions. The predominant seizure type(s) in a given individual vary depending on which clinical syndrome is present.</p><p>The most common <i>GRIN2A</i>-related speech disorder and epilepsy is epilepsy-aphasia syndromes (EAS), a spectrum of disorders that includes: Landau-Kleffner syndrome (LKS); epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS); childhood epilepsy with centrotemporal spikes (CECTS); atypical childhood epilepsy with centrotemporal spikes (ACECTS); and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> rolandic epilepsy with speech dyspraxia (ADRESD) [<a class="bk_pop" href="#grin2a-dis.REF.tsai.2013.280">Tsai et al 2013</a>]. Other epilepsy phenotypes can be broadly divided into infantile-onset epileptic encephalopathy and unclassified childhood epilepsy.</p><p><b>Landau-Kleffner syndrome (LKS)</b> [<a class="bk_pop" href="#grin2a-dis.REF.landau.1957.523">Landau &#x00026; Kleffner 1957</a>, <a class="bk_pop" href="#grin2a-dis.REF.wang.2006.105">Wang et al 2006</a>, <a class="bk_pop" href="#grin2a-dis.REF.hughes.2011.247">Hughes 2011</a>]</p><ul><li class="half_rhythm"><div>Onset in childhood (peak age range 5-8 years)</div></li><li class="half_rhythm"><div>Acquired aphasia, with auditory agnosia (impaired recognition of sounds) frequently described as the earliest feature</div></li><li class="half_rhythm"><div>Seizures in approximately 70% of cases, most commonly atypical absence, with focal motor, atonic, and focal seizures evolving to bilateral tonic-clonic seizures also described</div></li><li class="half_rhythm"><div>Developmental regression limited to language domains</div></li><li class="half_rhythm"><div>Normal development prior to onset of aphasia or <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> language impairment</div></li><li class="half_rhythm"><div>EEG showing frequent, sleep-activated, bilateral sharp and slow wave discharges (centrotemporal or perisylvian field), eventually evolving to continuous spike-and-wave in sleep (CSWS)</div></li></ul><p><b>Epileptic encephalopathy with continuous spike-and-wave during sleep</b>
<b>(ECSWS)</b> [<a class="bk_pop" href="#grin2a-dis.REF.van_bogaert.2013.635">Van Bogaert 2013</a>]</p><ul><li class="half_rhythm"><div>Onset in childhood (peak age range 4-5 years)</div></li><li class="half_rhythm"><div>Seizures in approximately 80% of cases, most commonly hemiclonic or generalized tonic-clonic in sleep and atypical absence while awake</div></li><li class="half_rhythm"><div>Global developmental regression (as distinct from the pure language regression of LKS)</div></li><li class="half_rhythm"><div>EEG showing near-continuous (&#x0003e;85% of recording), bilateral sharp and slow wave discharges in slow wave sleep (i.e., CSWS)</div></li></ul><p><b>Childhood epilepsy with centrotemporal spikes (CECTS)</b> [<a class="bk_pop" href="#grin2a-dis.REF.guerrini.2012.9">Guerrini &#x00026; Pellacani 2012</a>]</p><ul><li class="half_rhythm"><div>Onset is in childhood (peak age range 5-8 years; range 3-13 years).</div></li><li class="half_rhythm"><div>Seizures have a characteristic aura of perioral paresthesia which may involve the tongue, cheeks, and mouth. There is often speech arrest and a motor component involving the oropharyngeal muscles, unilateral facial tonic or clonic activity, and (less commonly) an upper limb. The majority of events occur during sleep, and classically involve drooling. Bilateral tonic-clonic seizures are also commonly observed.</div></li><li class="half_rhythm"><div>Seizure frequency is low: half of patients have fewer than six seizures in their lifetime.</div></li><li class="half_rhythm"><div>Epilepsy follows a self-limited course with duration less than five years in the majority of individuals.</div></li><li class="half_rhythm"><div>Development is essentially normal, though mild deficits in language, computation, and motor skills may be apparent when compared to healthy controls [<a class="bk_pop" href="#grin2a-dis.REF.staden.1998.242">Staden et al 1998</a>, <a class="bk_pop" href="#grin2a-dis.REF.lillywhite.2009.2276">Lillywhite et al 2009</a>, <a class="bk_pop" href="#grin2a-dis.REF.garciaramos.2015.1615">Garcia-Ramos et al 2015</a>].</div></li><li class="half_rhythm"><div>EEG background is normal and shows focal epileptiform discharges from the centrotemporal regions, potentiated in sleep. In 40% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, the centrotemporal discharges are bilateral and independent.</div></li></ul><p><b>Atypical childhood epilepsy with centrotemporal spikes (ACECTS)</b> [<a class="bk_pop" href="#grin2a-dis.REF.aicardi.1982.281">Aicardi &#x00026; Chevrie 1982</a>]</p><ul><li class="half_rhythm"><div>Epilepsy course is similar to CECTS with onset and spontaneous remission occurring in childhood.</div></li><li class="half_rhythm"><div>Seizures are different from those seen in CECTS, and include negative myoclonus and atypical absence seizures.</div></li><li class="half_rhythm"><div>Developmental regression or slowing is coincident with seizure onset; however, long-term developmental outcome may be normal.</div></li><li class="half_rhythm"><div>EEG is similar to CECTS in that focal centrotemporal discharges potentiated in sleep are seen; however, focal or diffuse background slowing is also often present.</div></li></ul><p><b>Autosomal dominant rolandic epilepsy with speech dyspraxia (ADRESD)</b> [<a class="bk_pop" href="#grin2a-dis.REF.scheffer.2000.s19">Scheffer 2000</a>, <a class="bk_pop" href="#grin2a-dis.REF.turner.2015b.35">Turner et al 2015b</a>]</p><ul><li class="half_rhythm"><div>Seizure characteristics and epilepsy course are identical to CECTS in most family members. One individual had an encephalopathic presentation associated with cognitive regression.</div></li><li class="half_rhythm"><div>Affected individuals have oral and speech dyspraxia with dysarthria.</div></li><li class="half_rhythm"><div>Individuals may have <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> speech dysfunction without seizures.</div></li><li class="half_rhythm"><div>Cognitive function is usually within the normal range.</div></li></ul><p><b>Infantile-onset epileptic encephalopathy</b> [<a class="bk_pop" href="#grin2a-dis.REF.endele.2010.1021">Endele et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.yuan.2014.3251">Yuan et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.allen.2016.e12">Allen et al 2016</a>]</p><ul><li class="half_rhythm"><div>Multiple different seizure types may be present, including tonic seizures, focal impaired awareness with evolution to bilateral seizures, infantile spasms, and myoclonic seizures.</div></li><li class="half_rhythm"><div>Severe intellectual disability was seen in the three individuals reported.</div></li><li class="half_rhythm"><div>EEG findings vary in the few reported cases and include background slowing, hypsarrhythmia, and focal spikes.</div></li><li class="half_rhythm"><div>Brain MRI may show bilateral parenchymal volume loss and thin corpus callosum.</div></li></ul><p><b>Unclassified childhood-onset epilepsy</b> [<a class="bk_pop" href="#grin2a-dis.REF.reutlinger.2010.1870">Reutlinger et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.devries.2013.482">DeVries &#x00026; Patel 2013</a>]</p><ul><li class="half_rhythm"><div>Focal seizures are the most commonly seen; myoclonic, eyelid myoclonia, and atypical absence have also been reported.</div></li><li class="half_rhythm"><div>Development ranges from normal to severely impaired.</div></li><li class="half_rhythm"><div>Mild <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features may be present in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a>.</div></li><li class="half_rhythm"><div>EEG usually shows multifocal epileptiform discharges.</div></li></ul><p><b>Contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions.</b>
<a class="bk_pop" href="#grin2a-dis.REF.reutlinger.2010.1870">Reutlinger et al [2010]</a> described three individuals with 16p13 deletions involving multiple genes and complete or partial <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>GRIN2A</i>. All had mild <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features, intellectual disability, and epilepsy involving the rolandic region.</p><p><b>EEG</b> most commonly shows bilateral epileptiform discharges (usually spike or spike-wave) in the central-temporal or temporal-parietal regions which may be independent or bilaterally synchronous. These abnormalities become more frequent in sleep, often evolving to continuous spike-and-wave in sleep (CSWS). CSWS is defined as near-continuous (&#x0003e;85% of non-REM sleep recording) bilateral sharp and slow wave discharges in slow wave sleep. CECTS is classically associated with a horizontal dipole; tangential dipole across the Sylvian fissure has been reported in LKS [<a class="bk_pop" href="#grin2a-dis.REF.morrell.1995.1529">Morrell et al 1995</a>, <a class="bk_pop" href="#grin2a-dis.REF.dalla_bernardina.2005">Dalla Bernardina et al 2005</a>].</p><p><b>Brain imaging.</b> Brain MRI is normal in the vast majority. Severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may have enlargement of extra-axial spaces and a thin corpus callosum [<a class="bk_pop" href="#grin2a-dis.REF.reutlinger.2010.1870">Reutlinger et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.pierson.2014.190">Pierson et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.yuan.2014.3251">Yuan et al 2014</a>]. One individual with focal cortical dysplasia was reported [<a class="bk_pop" href="#grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</a>].</p><p>Positron emission tomography (PET) showing diffuse cortical hypometabolism was reported in one individual [<a class="bk_pop" href="#grin2a-dis.REF.devries.2013.482">DeVries &#x00026; Patel 2013</a>].</p></div><div id="grin2a-dis.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation is observed in a number of families in which all individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have an epilepsy-aphasia syndrome (EAS) phenotype. However, the specific EAS phenotype may vary considerably within the family, including one individual with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> speech dysfunction and another with epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS) [<a class="bk_pop" href="#grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.turner.2015a.586">Turner et al 2015a</a>].</p><p>For single-nucleotide variants (SNVs) and small intragenic copy number variants (CNVs), the <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> region in which the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurs does not appear to have any relationship to the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Specifically, the pathogenic variants associated with infantile-onset epileptic encephalopathies do not cluster in a region distinct from the location of pathogenic variants associated with the epilepsy-aphasia syndromes (EAS).</p></div><div id="grin2a-dis.Penetrance"><h3>Penetrance</h3><p><i>GRIN2A</i>-related speech disorders and epilepsy show incomplete but high <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>.</p><p>Penetrance is not clearly different for males and females.</p></div><div id="grin2a-dis.Nomenclature"><h3>Nomenclature</h3><p>Landau-Kleffner syndrome (LKS) has also been referred to as epileptic acquired aphasia.</p><p>Epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS) has also been referred to as continuous spike-and-wave during slow-wave sleep (CSWS) and electrical status epilepticus during sleep (ESES).</p><p>Childhood epilepsy with centrotemporal spikes (CECTS) has been commonly referred to as benign epilepsy with centrotemporal spikes (BECTS) and benign rolandic epilepsy of childhood (BREC).</p><p>Atypical childhood epilepsy with centrotemporal spikes (ACECTS) has been known as atypical benign partial epilepsy (ABPE), pseudo-Lennox syndrome, and atonic-benign childhood epilepsy with centrotemporal spikes.</p></div><div id="grin2a-dis.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>GRIN2A</i>-related speech disorders and epilepsy in the general population is unknown; however, estimates can be made for some of the classic disorders.</p><p><i>GRIN2A</i> pathogenic variants account for 9%-20% of epilepsy-aphasia syndrome (EAS), with pathogenic variants more likely to be present in persons with more severe phenotypes and a positive family history [<a class="bk_pop" href="#grin2a-dis.REF.lesca.2012.1526">Lesca et al 2012</a>, <a class="bk_pop" href="#grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</a>].</p><p><i>GRIN2A</i> pathogenic variants are present in:</p><ul><li class="half_rhythm"><div>4.8%-7.7% of Landau-Kleffner syndrome (LKS)</div></li><li class="half_rhythm"><div>17.6% of epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS)</div></li><li class="half_rhythm"><div>0%-4.9% of childhood epilepsy with centrotemporal spikes (CECTS)</div></li><li class="half_rhythm"><div>13.5% of atypical childhood epilepsy with centrotemporal spikes (ACECTS)</div></li><li class="half_rhythm"><div>2% of early-onset epileptic encephalopathy</div></li></ul><p>[<a class="bk_pop" href="#grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.conroy.2014.858">Conroy et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.allen.2016.e12">Allen et al 2016</a>].</p></div></div><div id="grin2a-dis.Genetically_Related_Allelic_D"><h2 id="_grin2a-dis_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be definitely associated with pathogenic variants in <i>GRIN2A</i>.</p></div><div id="grin2a-dis.Differential_Diagnosis"><h2 id="_grin2a-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Non-<i>GRIN2</i>-related genetic epilepsy</b></p><ul><li class="half_rhythm"><div>Epilepsy-aphasia syndrome (EAS). While <i>GRIN2A</i> is the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> most commonly associated with EAS, the majority of individuals with this group of syndromes do not have an identified genetic cause. A number of CNVs have been associated with EAS in individual cases. Pathogenic variants in <i>RBFOX1</i> and <i>RBFOX3</i> may play a contributory role in some cases [<a class="bk_pop" href="#grin2a-dis.REF.lal.2013.e73323">Lal et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.turner.2015b.35">Turner et al 2015b</a>]. At present, no clinical features differentiate <i>GRIN2A</i>-related EAS from EAS of other genetic causes.</div></li><li class="half_rhythm"><div>Non-EAS childhood-onset focal epilepsy and infantile-onset epileptic encephalopathy. Each <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has only a small number of reported cases associated with a <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Clinical data currently available are insufficient to distinguish those with a <i>GRIN2A</i> pathogenic variant from those with other genetic causes.</div></li></ul><p><b>Non-genetic causes of epilepsy.</b> Focal epilepsy and epileptic encephalopathy may have many non-genetic causes, including autoimmune and infectious processes. A non-genetic cause should be more strongly considered when a history of any of the following is present:</p><ul><li class="half_rhythm"><div>Maternal substance abuse during pregnancy</div></li><li class="half_rhythm"><div>Significant complications in the perinatal period</div></li><li class="half_rhythm"><div>Significant cerebral insult (e.g., central nervous system infection, hypoxic-ischemic injury, major head trauma, toxic ingestion/exposure)</div></li></ul><p><b>Non-<i>GRIN2A</i>-related genetic language impairment.</b> A severe speech and language disorder that primarily involves developmental verbal dyspraxia is caused by pthogenic variants in <i>FOXP2</i> (see <a href="/books/n/gene/foxp2-sl-dis/"><i>FOXP2</i>-Related Speech and Language Disorders</a>) [<a class="bk_pop" href="#grin2a-dis.REF.lai.2001.519">Lai et al 2001</a>]. <i>FOXP2</i> regulates <i>CNTNAP2</i>, and <i>CNTNAP2</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and deletions have been associated with childhood apraxia of speech; however, evidence of a causative link is at present limited [<a class="bk_pop" href="#grin2a-dis.REF.worthey.2013.29">Worthey et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.centanni.2015.536">Centanni et al 2015</a>].</p><p><b>Hearing impairment</b> is a common cause of language-specific developmental delay or regression, thus in children with delayed speech development or regression in speech, the auditory system should be assessed (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>).</p><p><b>Structural brain abnormality.</b> Brain malformations and acquired structural brain anomalies can present with a constellation of symptoms that can mimic the <i>GRIN2A</i>-related disorders. Worster-Drought syndrome (OMIM <a href="http://omim.org/entry/185480" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">185480</a>) involves <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> bilateral perisylvian lesions, most commonly polymicrogyria [<a class="bk_pop" href="#grin2a-dis.REF.christen.2000.122">Christen et al 2000</a>]. Affected children typically have seizures, expressive language delay, dysarthria, and oromotor apraxia.</p></div><div id="grin2a-dis.Management"><h2 id="_grin2a-dis_Management_">Management</h2><div id="grin2a-dis.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with a <i>GRIN2A</i>-related speech disorder and epilepsy, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Consultation with a speech and language pathologist</div></li><li class="half_rhythm"><div>Epilepsy consultation (if not done at the time of initial assessment)</div></li><li class="half_rhythm"><div>Sleep-deprived or sleep EEG with monitoring to capture slow-wave sleep (if not done at the time of initial assessment), as this is essential to diagnosing or excluding continuous spike-and-wave in sleep (CSWS).</div></li><li class="half_rhythm"><div>Neuropsychological assessment</div></li><li class="half_rhythm"><div>Hearing testing</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="grin2a-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Speech/language deficits.</b> Individuals with significant speech/language deficits may benefit from therapy by a speech pathologist. The therapies, which are individualized to the specific speech disorder, often include linguistic approaches and augmentative and alternative communication [<a class="bk_pop" href="#grin2a-dis.REF.murray.2014.486">Murray et al 2014</a>].</p><p><b>Seizures,</b> if present, should be treated with antiepileptic drugs (AEDs). Many different AEDs may be effective, and no one medication has been demonstrated to be effective specifically for <i>GRIN2A</i>-related disorders.</p><p>In one individual a good response to refractory epilepsy was achieved with topiramate [<a class="bk_pop" href="#grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran et al 2014</a>].</p><p>In one individual seizure burden was reduced with the addition of memantine; however, cognitive function did not improve [<a class="bk_pop" href="#grin2a-dis.REF.pierson.2014.190">Pierson et al 2014</a>].</p><p>Ketogenic diet and vagal nerve stimulator may also be considered in patients with refractory epilepsy.</p><p>Treatment for epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS) and Landau-Kleffner syndrome (LKS) includes AEDs such as valproic acid, benzodiazepines, and corticosteroids. Sulthiame, ethosuximide, and levetiracetam may also be effective.</p><p>Of note, intravenous immunoglobulin has not been proven to be efficacious [<a class="bk_pop" href="#grin2a-dis.REF.striano.2013.360">Striano &#x00026; Capovilla 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.van_bogaert.2013.635">Van Bogaert 2013</a>].</p><p><b>Caregivers.</b> For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p></div><div id="grin2a-dis.Prevention_of_Secondary_Compl"><h3>Prevention of Secondary Complications</h3><p><b>AEDs</b> are associated with possible adverse reactions (e.g., sedation, gastrointestinal symptoms, changes in appetite [increase or decrease], weight gain or loss, and rash) which vary according to the specific medication. Patients on AEDs should be monitored closely for adverse reactions and, if they develop, a change to an alternate AED should be considered.</p><p><b>Corticosteroids</b> are associated with a wide variety of possible adverse reactions, including weight gain with cushingoid appearance, skin thinning and purpura, alopecia, acne, posterior subscapular cataract, glaucoma, exophthalmos, cardiac arrhythmias, hypertension, gastrointestinal upset, pancreatitis, hypokalemia, osteoporosis, avascular necrosis, myopathy, behavioral/psychiatric disturbance, diabetes mellitus, adrenal insufficiency, and increased infection risk. If complications of corticosteroid therapy become of concern, gradual tapering and alternate therapy should be considered.</p></div><div id="grin2a-dis.Surveillance"><h3>Surveillance</h3><p>Routine monitoring of speech and language by a speech pathologist should be considered for all children, particularly those diagnosed before reaching school age.</p><p>Developmental surveillance should be conducted in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children.</p></div><div id="grin2a-dis.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>In individuals with epileptic encephalopathy with continuous spike-and-wave during sleep (ECSWS), phenytoin, barbiturates and carbamazepine should be avoided as they are rarely effective, may worsen the EEG, and have negative effects on neuropsychological outcomes [<a class="bk_pop" href="#grin2a-dis.REF.striano.2013.360">Striano &#x00026; Capovilla 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.van_bogaert.2013.635">Van Bogaert 2013</a>].</p></div><div id="grin2a-dis.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>Using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, it is appropriate to evaluate apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from institution of treatment. Of note, some individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>GRIN2A</i> pathogenic variant who have only relatively mild speech dysfunction may benefit from early evaluation and intervention by a speech and language pathologist.</p><p>See <a href="#grin2a-dis.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="grin2a-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="grin2a-dis.Genetic_Counseling"><h2 id="_grin2a-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="grin2a-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>GRIN2A</i>-related speech disorders and epilepsy are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="grin2a-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with a <i>GRIN2A</i>-related speech disorder and epilepsy have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. There is considerable clinical variability within families.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>GRIN2A</i>-related speech disorder and epilepsy may have a <i>de novo GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; however, the proportion of <i>GRIN2A</i>-related speech disorders and epilepsy caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant is unknown because to date an insufficient number of parents of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) have been tested.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. (Although no instances of germline mosaicism have been reported, it remains a possibility.)</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with a <i>GRIN2A</i>-related speech disorder and epilepsy may appear to be negative because of failure to recognize the disorder in family members, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, or variable clinical severity. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents. If the parents have been tested for the <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband and:</div><ul><li class="half_rhythm"><div>A parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%. Some <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases have demonstrated reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and phenotypic variability.</div></li><li class="half_rhythm"><div>The <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be low but greater than that of the general population because of the theoretic possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, sibs of a proband with clinically unaffected parents are still presumed to be at increased risk for a <i>GRIN2A</i>-related speech disorder and epilepsy because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a <i>GRIN2A</i>-related speech disorder and epilepsy has a 50% chance of inheriting the <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Some <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases have demonstrated reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and phenotypic variability.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="grin2a-dis.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#grin2a-dis.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="grin2a-dis.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>GRIN2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for a <i>GRIN2A</i>-related speech disorder and epilepsy are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="grin2a-dis.Resources"><h2 id="_grin2a-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="http://www.ninds.nih.gov/disorders/epilepsy/epilepsy.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy Information Page</a></div></li></ul></div><div id="grin2a-dis.Molecular_Genetics"><h2 id="_grin2a-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="grin2a-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>GRIN2A-Related Speech Disorders and Epilepsy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK385627/table/grin2a-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__grin2a-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_grin2a-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_grin2a-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_grin2a-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_grin2a-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_grin2a-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_grin2a-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2903" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GRIN2A</i></a></td><td headers="hd_b_grin2a-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2903" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_grin2a-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q12879" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Glutamate receptor ionotropic, NMDA 2A</a></td><td headers="hd_b_grin2a-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GRIN2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GRIN2A</a></td><td headers="hd_b_grin2a-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GRIN2A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GRIN2A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="grin2a-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="grin2a-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for GRIN2A-Related Speech Disorders and Epilepsy (<a href="/omim/138253,245570" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK385627/table/grin2a-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__grin2a-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/138253" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">138253</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE, SUBUNIT 2A; GRIN2A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/245570" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">245570</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD</td></tr></tbody></table></div></div><div id="grin2a-dis.Molecular_Genetic_Pathogenesi"><h3>Molecular Genetic Pathogenesis</h3><p>N-methyl-D-aspartate (NMDA) receptors are glutamate-activated ion channels permeable to sodium, calcium, and potassium ions, thought to be primarily important in mediation of excitatory processes in the human brain. The NMDA receptor is a heterotetramer composed of two NMDA-receptor 1 subunits (NR1) and two different NMDA-receptor subunits (NR2A and NR2B). The NR2A subunit is encoded by <i>GRIN2A</i> [<a class="bk_pop" href="#grin2a-dis.REF.matta.2011.339">Matta et al 2011</a>].</p><p><b>Gene structure.</b>
<i>GRIN2A</i> comprises 14 exons [<a class="bk_pop" href="#grin2a-dis.REF.endele.2010.1021">Endele et al 2010</a>]. See <a href="/books/NBK385627/#grin2a-dis.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Of probands with pathogenic variants, 41/71 (58%) had <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, 8/71 (11%) <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, 8/71 (11%) <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, and 13/71 (18%) copy number variations; the remaining <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> had a <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> affecting <i>GRIN2A</i> without loss of genetic material.</p><p>One recurrent <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant (c.1007+1G&#x0003e;A) located in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 4 has been identified in six apparently unrelated probands [<a class="bk_pop" href="#grin2a-dis.REF.carvill.2013.1073">Carvill et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</a>]. Four <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (c.1553G&#x0003e;A, c.1845C&#x0003e;A, c.2146G&#x0003e;A, and c.2927A&#x0003e;G) have been reported in two probands each [<a class="bk_pop" href="#grin2a-dis.REF.endele.2010.1021">Endele et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.lesca.2013.1061">Lesca et al 2013</a>, <a class="bk_pop" href="#grin2a-dis.REF.conroy.2014.858">Conroy et al 2014</a>, <a class="bk_pop" href="#grin2a-dis.REF.allen.2016.e12">Allen et al 2016</a>, <a class="bk_pop" href="#grin2a-dis.REF.fainberg.2016.97">Fainberg et al 2016</a>].</p><p>In two nonfamilial cases, a recurrent <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.1845C&#x0003e;A) has been associated with severe intellectual disability and refractory early-onset epileptic encephalopathy [<a class="bk_pop" href="#grin2a-dis.REF.endele.2010.1021">Endele et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.allen.2016.e12">Allen et al 2016</a>].</p><div id="grin2a-dis.T.grin2a_pathogenic_variants" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>GRIN2A</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK385627/table/grin2a-dis.T.grin2a_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__grin2a-dis.T.grin2a_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1007+1G&#x0003e;A</td><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Splice region</td><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000833.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000833<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_000824.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000824<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1553G&#x0003e;A</td><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg518His</td></tr><tr><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1845C&#x0003e;A</td><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn615Lys</td></tr><tr><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2146G&#x0003e;A</td><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala716Thr</td></tr><tr><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2927A&#x0003e;G</td><td headers="hd_h_grin2a-dis.T.grin2a_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn976Ser</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society <a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">(varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The human <i>GRIN2A</i> gene product contains 1464 amino acids.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> In in vitro models, NMDA receptors with <i>GRIN2A</i> pathogenic variants demonstrate reduced inhibition by both Zn<sup>2+</sup> and Mg<sup>2+</sup>, and have shorter closed-state and longer open-state durations, all of which suggests that <i>GRIN2A</i> pathogenic variants lead to increased neuronal excitability [<a class="bk_pop" href="#grin2a-dis.REF.endele.2010.1021">Endele et al 2010</a>, <a class="bk_pop" href="#grin2a-dis.REF.lesca.2012.1526">Lesca et al 2012</a>, <a class="bk_pop" href="#grin2a-dis.REF.lemke.2013.1067">Lemke et al 2013</a>].</p></div></div><div id="grin2a-dis.References"><h2 id="_grin2a-dis_References_">References</h2><div id="grin2a-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.aicardi.1982.281">Aicardi J, Chevrie JJ. Atypical benign partial epilepsy of childhood. <span><span class="ref-journal">Dev Med Child Neurol. </span>1982;<span class="ref-vol">24</span>:281–92.</span> [<a href="/pubmed/6807733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6807733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.allen.2016.e12">Allen NM, Conroy J, Shahwan A, Lynch B, Correa RG, Pena SD, McCreary D, Magalhaes TR, Ennis S, Lynch SA, King MD. Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion. <span><span class="ref-journal">Epilepsia. </span>2016;<span class="ref-vol">57</span>:e12–7.</span> [<a href="/pubmed/26648591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26648591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.carvill.2013.1073">Carvill GL, Regan BM, Yendle SC, O'Roak BJ, Lozovaya N, Bruneau N, Burnashev N, Khan A, Cook J, Geraghty E, Sadleir LG, Turner SJ, Tsai MH, Webster R, Ouvrier R, Damiano JA, Berkovic SF, Shendure J, Hildebrand MS, Szepetowski P, Scheffer IE, Mefford HC. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:1073–6.</span> [<a href="/pmc/articles/PMC3868952/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3868952</span></a>] [<a href="/pubmed/23933818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23933818</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.centanni.2015.536">Centanni TM, Sanmann JN, Green JR, Iuzzini-Seigel J, Bartlett C, Sanger WG, Hogan TP. The role of candidate-gene <em>CNTNAP2</em> in childhood apraxia of speech and specific language impairment. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2015;<span class="ref-vol">168</span>:536–43.</span> [<a href="/pubmed/26097074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26097074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.christen.2000.122">Christen HJ, Hanefeld F, Kruse E, Imhauser S, Ernst JP, Finkenstaedt M. Foix-Chavany-Marie (anterior operculum) syndrome in childhood: a reappraisal of Worster-Drought syndrome. <span><span class="ref-journal">Dev Med Child Neurol. </span>2000;<span class="ref-vol">42</span>:122–32.</span> [<a href="/pubmed/10698330" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10698330</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.conroy.2014.858">Conroy J, McGettigan PA, McCreary D, Shah N, Collins K, Parry-Fielder B, Moran M, Hanrahan D, Deonna TW, Korff CM, Webb D, Ennis S, Lynch SA, King MD. Towards the identification of a genetic basis for Landau-Kleffner syndrome. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:858–65.</span> [<a href="/pubmed/24828792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24828792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.dalla_bernardina.2005">Dalla Bernardina B, Sgr&#x000f2; V, Fejerman N. Epilepsy with centro-temporal spikes and related syndromes. In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, eds. <em>Epileptic Syndromes in Infancy, Childhood and Adolescence.</em> 4 ed. Montrouge, France, John Libbey Eurotext. 2005:203-26.</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.devries.2013.482">DeVries SP, Patel AD. Two patients with a GRIN2A mutation and childhood-onset epilepsy. <span><span class="ref-journal">Pediatr Neurol. </span>2013;<span class="ref-vol">49</span>:482–5.</span> [<a href="/pubmed/24125812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24125812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.dimassi.2014.370">Dimassi S, Labalme A, Lesca G, Rudolf G, Bruneau N, Hirsch E, Arzimanoglou A, Motte J, de Saint Martin A, Boutry-Kryza N, Cloarec R, Benitto A, Ameil A, Edery P, Ryvlin P, De Bellescize J, Szepetowski P, Sanlaville D. A subset of genomic alterations detected in rolandic epilepsies contains candidate or known epilepsy genes including GRIN2A and PRRT2. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:370–8.</span> [<a href="/pubmed/24372385" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24372385</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.endele.2010.1021">Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kortum F, Fritsch A, Pientka FK, Hellenbroich Y, Kalscheuer VM, Kohlhase J, Moog U, Rappold G, Rauch A, Ropers HH, von Spiczak S, Tonnies H, Villeneuve N, Villard L, Zabel B, Zenker M, Laube B, Reis A, Wieczorek D, Van Maldergem L, Kutsche K. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:1021–6.</span> [<a href="/pubmed/20890276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20890276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.fainberg.2016.97">Fainberg N, Harper A, Tchapyjnikov D, Mikati MA. Response to immunotherapy in a patient with Landau-Kleffner syndrome and GRIN2A mutation. <span><span class="ref-journal">Epileptic Disord. </span>2016;<span class="ref-vol">18</span>:97–100.</span> [<a href="/pubmed/26806548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26806548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.garciaramos.2015.1615">Garcia-Ramos C, Jackson DC, Lin JJ, Dabbs K, Jones JE, Hsu DA, Stafstrom CE, Zawadzki L, Seidenberg M, Prabhakaran V, Hermann BP. Cognition and brain development in children with benign epilepsy with centrotemporal spikes. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:1615–22.</span> [<a href="/pmc/articles/PMC4593750/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4593750</span></a>] [<a href="/pubmed/26337046" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26337046</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.guerrini.2012.9">Guerrini R, Pellacani S. Benign childhood focal epilepsies. <span><span class="ref-journal">Epilepsia. </span>2012;<span class="ref-vol">53</span> Suppl 4:9–18.</span> [<a href="/pubmed/22946717" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22946717</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.hughes.2011.247">Hughes JR. A review of the relationships between Landau-Kleffner syndrome, electrical status epilepticus during sleep, and continuous spike-waves during sleep. <span><span class="ref-journal">Epilepsy Behav. </span>2011;<span class="ref-vol">20</span>:247–53.</span> [<a href="/pubmed/21242107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21242107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.lai.2001.519">Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. A forkhead-domain gene is mutated in a severe speech and language disorder. <span><span class="ref-journal">Nature. </span>2001;<span class="ref-vol">413</span>:519–23.</span> [<a href="/pubmed/11586359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11586359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.lal.2013.e73323">Lal D, Reinthaler EM, Altmuller J, Toliat MR, Thiele H, Nurnberg P, Lerche H, Hahn A, Moller RS, Muhle H, Sander T, Zimprich F, Neubauer BA. RBFOX1 and RBFOX3 mutations in rolandic epilepsy. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e73323.</span> [<a href="/pmc/articles/PMC3765197/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3765197</span></a>] [<a href="/pubmed/24039908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24039908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.landau.1957.523">Landau WM, Kleffner FR. Syndrome of acquired aphasia with convulsive disorder in children. <span><span class="ref-journal">Neurology. </span>1957;<span class="ref-vol">7</span>:523–30.</span> [<a href="/pubmed/13451887" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13451887</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.lemke.2013.1067">Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M, Geider K, Laube B, Schwake M, Finsterwalder K, Franke A, Schilhabel M, Jahn JA, Muhle H, Boor R, Van Paesschen W, Caraballo R, Fejerman N, Weckhuysen S, De Jonghe P, Larsen J, Moller RS, Hjalgrim H, Addis L, Tang S, Hughes E, Pal DK, Veri K, Vaher U, Talvik T, Dimova P, Guerrero Lopez R, Serratosa JM, Linnankivi T, Lehesjoki AE, Ruf S, Wolff M, Buerki S, Wohlrab G, Kroell J, Datta AN, Fiedler B, Kurlemann G, Kluger G, Hahn A, Haberlandt DE, Kutzer C, Sperner J, Becker F, Weber YG, Feucht M, Steinbock H, Neophythou B, Ronen GM, Gruber-Sedlmayr U, Geldner J, Harvey RJ, Hoffmann P, Herms S, Altmuller J, Toliat MR, Thiele H, Nurnberg P, Wilhelm C, Stephani U, Helbig I, Lerche H, Zimprich F, Neubauer BA, Biskup S, von Spiczak S. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:1067–72.</span> [<a href="/pubmed/23933819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23933819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.lesca.2013.1061">Lesca G, Rudolf G, Bruneau N, Lozovaya N, Labalme A, Boutry-Kryza N, Salmi M, Tsintsadze T, Addis L, Motte J, Wright S, Tsintsadze V, Michel A, Doummar D, Lascelles K, Strug L, Waters P, de Bellescize J, Vrielynck P, de Saint Martin A, Ville D, Ryvlin P, Arzimanoglou A, Hirsch E, Vincent A, Pal D, Burnashev N, Sanlaville D, Szepetowski P. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:1061–6.</span> [<a href="/pubmed/23933820" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23933820</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.lesca.2012.1526">Lesca G, Rudolf G, Labalme A, Hirsch E, Arzimanoglou A, Genton P, Motte J, de Saint Martin A, Valenti MP, Boulay C, De Bellescize J, Keo-Kosal P, Boutry-Kryza N, Edery P, Sanlaville D, Szepetowski P. Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism. <span><span class="ref-journal">Epilepsia. </span>2012;<span class="ref-vol">53</span>:1526–38.</span> [<a href="/pubmed/22738016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22738016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.lillywhite.2009.2276">Lillywhite LM, Saling MM, Harvey AS, Abbott DF, Archer JS, Vears DF, Scheffer IE, Jackson GD. Neuropsychological and functional MRI studies provide converging evidence of anterior language dysfunction in BECTS. <span><span class="ref-journal">Epilepsia. </span>2009;<span class="ref-vol">50</span>:2276–84.</span> [<a href="/pubmed/19292755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19292755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.matta.2011.339">Matta JA, Ashby MC, Sanz-Clemente A, Roche KW, Isaac JT. mGluR5 and NMDA receptors drive the experience- and activity-dependent NMDA receptor NR2B to NR2A subunit switch. <span><span class="ref-journal">Neuron. </span>2011;<span class="ref-vol">70</span>:339–51.</span> [<a href="/pmc/articles/PMC3087383/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3087383</span></a>] [<a href="/pubmed/21521618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21521618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.morrell.1995.1529">Morrell F, Whisler WW, Smith MC, Hoeppner TJ, de Toledo-Morrell L, Pierre-Louis SJ, Kanner AM, Buelow JM, Ristanovic R, Bergen D, Chez M, Hasegawa H. Landau-Kleffner syndrome. Treatment with subpial intracortical transection. <span><span class="ref-journal">Brain. </span>1995;<span class="ref-vol">118</span>:1529–46.</span> [<a href="/pubmed/8595482" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8595482</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.murray.2014.486">Murray E, McCabe P, Ballard KJ. A systematic review of treatment outcomes for children with childhood apraxia of speech. <span><span class="ref-journal">Am J Speech Lang Pathol. </span>2014;<span class="ref-vol">23</span>:486–504.</span> [<a href="/pubmed/24686844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24686844</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.pierson.2014.190">Pierson TM, Yuan H, Marsh ED, Fuentes-Fajardo K, Adams DR, Markello T, Golas G, Simeonov DR, Holloman C, Tankovic A, Karamchandani MM, Schreiber JM, Mullikin JC, Tifft CJ, Toro C, Boerkoel CF, Traynelis SF, Gahl WA. GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine. <span><span class="ref-journal">Ann Clin Transl Neurol. </span>2014;<span class="ref-vol">1</span>:190–8.</span> [<a href="/pmc/articles/PMC4019449/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4019449</span></a>] [<a href="/pubmed/24839611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24839611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.reutlinger.2010.1870">Reutlinger C, Helbig I, Gawelczyk B, Subero JI, Tonnies H, Muhle H, Finsterwalder K, Vermeer S, Pfundt R, Sperner J, Stefanova I, Gillessen-Kaesbach G, von Spiczak S, van Baalen A, Boor R, Siebert R, Stephani U, Caliebe A. Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region. <span><span class="ref-journal">Epilepsia. </span>2010;<span class="ref-vol">51</span>:1870–3.</span> [<a href="/pubmed/20384727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20384727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.scheffer.2000.s19">Scheffer IE. Autosomal dominant rolandic epilepsy with speech dyspraxia. <span><span class="ref-journal">Epileptic Disord. </span>2000;<span class="ref-vol">2</span> Suppl 1:S19–22.</span> [<a href="/pubmed/11231219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11231219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.staden.1998.242">Staden U, Isaacs E, Boyd SG, Brandl U, Neville BG. Language dysfunction in children with Rolandic epilepsy. <span><span class="ref-journal">Neuropediatrics. </span>1998;<span class="ref-vol">29</span>:242–8.</span> [<a href="/pubmed/9810559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9810559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.striano.2013.360">Striano P, Capovilla G. Epileptic encephalopathy with continuous spikes and waves during sleep. <span><span class="ref-journal">Curr Neurol Neurosci Rep. </span>2013;<span class="ref-vol">13</span>:360.</span> [<a href="/pubmed/23666433" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23666433</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.tsai.2013.280">Tsai MH, Vears DF, Turner SJ, Smith RL, Berkovic SF, Sadleir LG, Scheffer IE. Clinical genetic study of the epilepsy-aphasia spectrum. <span><span class="ref-journal">Epilepsia. </span>2013;<span class="ref-vol">54</span>:280–7.</span> [<a href="/pubmed/23294109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23294109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.turner.2015a.586">Turner SJ, Mayes AK, Verhoeven A, Mandelstam SA, Morgan AT, Scheffer IE. GRIN2A: an aptly named gene for speech dysfunction. <span><span class="ref-journal">Neurology. </span>2015a;<span class="ref-vol">84</span>:586–93.</span> [<a href="/pmc/articles/PMC4335991/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4335991</span></a>] [<a href="/pubmed/25596506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25596506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.turner.2015b.35">Turner SJ, Morgan AT, Perez ER, Scheffer IE. New genes for focal epilepsies with speech and language disorders. <span><span class="ref-journal">Curr Neurol Neurosci Rep. </span>2015b;<span class="ref-vol">15</span>:35.</span> [<a href="/pubmed/25921602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25921602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.van_bogaert.2013.635">Van Bogaert P. Epileptic encephalopathy with continuous spike-waves during slow-wave sleep including Landau-Kleffner syndrome. <span><span class="ref-journal">Handb Clin Neurol. </span>2013;<span class="ref-vol">111</span>:635–40.</span> [<a href="/pubmed/23622211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23622211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.venkateswaran.2014.e75">Venkateswaran S, Myers KA, Smith AC, Beaulieu CL, Schwartzentruber JA, Majewski J, Bulman D, Boycott KM, Dyment DA. Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:e75–9.</span> [<a href="/pubmed/24903190" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24903190</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.wang.2006.105">Wang S, Zhang YH, Bao XH, Wu Y, Jiang YW, Liu XY, Qin J. <span><span class="ref-journal">Zhonghua Er Ke Za Zhi. </span>2006;<span class="ref-vol">44</span>:105–9.</span> [Clinical characteristics and long-term prognosis of Landau-Kleffner syndrome] [<a href="/pubmed/16624025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16624025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.worthey.2013.29">Worthey EA, Raca G, Laffin JJ, Wilk BM, Harris JM, Jakielski KJ, Dimmock DP, Strand EA, Shriberg LD. Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech. <span><span class="ref-journal">J Neurodev Disord. </span>2013;<span class="ref-vol">5</span>:29.</span> [<a href="/pmc/articles/PMC3851280/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3851280</span></a>] [<a href="/pubmed/24083349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24083349</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="grin2a-dis.REF.yuan.2014.3251">Yuan H, Hansen KB, Zhang J, Pierson TM, Markello TC, Fajardo KV, Holloman CM, Golas G, Adams DR, Boerkoel CF, Gahl WA, Traynelis SF. Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy. <span><span class="ref-journal">Nat Commun. </span>2014;<span class="ref-vol">5</span>:3251.</span> [<a href="/pmc/articles/PMC3934797/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3934797</span></a>] [<a href="/pubmed/24504326" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24504326</span></a>]</div></li></ul></div></div><div id="grin2a-dis.Chapter_Notes"><h2 id="_grin2a-dis_Chapter_Notes_">Chapter Notes</h2><div id="grin2a-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 September 2016 (bp) Review posted live</div></li><li class="half_rhythm"><div>12 October 2015 (kam) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK385627</span><span class="label">PMID: <a href="/pubmed/27683935" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">27683935</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/grin1-ndd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/grin2b/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK385627&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK385627/?report=reader">PubReader</a></li><li><a href="/books/NBK385627/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK385627" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK385627" style="display:none" title="Cite this Page"><div class="bk_tt">Myers KA, Scheffer IE. GRIN2A-Related Speech Disorders and Epilepsy. 2016 Sep 29. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK385627/pdf/Bookshelf_NBK385627.pdf">PDF version of this page</a> (447K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#grin2a-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#grin2a-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#grin2a-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#grin2a-dis.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#grin2a-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#grin2a-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#grin2a-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#grin2a-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#grin2a-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#grin2a-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#grin2a-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2903[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GRIN2A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4326154" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4326154" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4326154" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4326154" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301494" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SCN1A</i> Seizure Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Miller IO, Sotero de Menezes MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29056244" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">GRIN2A mutations in epilepsy-aphasia spectrum disorders.</a><span class="source">[Brain Dev. 2018]</span><div class="brieflinkpop offscreen_noflow">GRIN2A mutations in epilepsy-aphasia spectrum disorders.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yang X, Qian P, Xu X, Liu X, Wu X, Zhang Y, Yang Z. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain Dev. 2018 Mar; 40(3):205-210. Epub 2017 Oct 19.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234941" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gertler T, Bearden D, Bhattacharjee A, Carvill G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27905812" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">STXBP1</i> Encephalopathy with Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">STXBP1</i> Encephalopathy with Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Khaikin Y, Mercimek-Mahmutoglu S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=27683935" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=27683935" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc952839a66ee2ba57c7bc">GRIN2A-Related Speech Disorders and Epilepsy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">GRIN2A-Related Speech Disorders and Epilepsy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:32:24-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AC4D3DFC869A1000000000709038E&amp;ncbi_session=CE8AC4D3DFC95271_1801SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK385627%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK385627&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK385627/&amp;ncbi_pagename=GRIN2A-Related Speech Disorders and Epilepsy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AC4D3DFC95271_1801SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>